Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Vulvar Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

  • Details

ClinicalTrials.gov ID: NCT04197986
Diagnosis Type: NA
USOR Number: 19094

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A phase 1 study of SEA-BCMA in patients with relapsed or refractory multiple myeloma (SGNBCMA-001)

  • Details

ClinicalTrials.gov ID: NCT03582033
Diagnosis Type: NA
USOR Number: 18126

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents (D8220R00004)

  • Details

ClinicalTrials.gov ID: NCT03816683
Diagnosis Type: NA
USOR Number: 18127

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b (MER-XMT-1536-1)

  • Details

ClinicalTrials.gov ID: NCT03319628
Diagnosis Type: NA
USOR Number: 19081

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b (MER-XMT-1536-1)

  • Details

ClinicalTrials.gov ID: NCT03319628
Diagnosis Type: NA
USOR Number: 19081

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

1800 Williams St, Suite 200
Denver, Colorado 80218
532.74 mi. away
P: (303) 388-4876

More Details View Practice Page

Pages